Abundance of calcareous nannofossils in ODP Hole 121-752B (Table 1)

A biostratigraphically complete Cretaceous/Tertiary boundary was recovered during Ocean Drilling Program Leg 121. The boundary, cored in ODP Hole 752B on Broken Ridge, is the most expanded deep-sea section yet recovered by ODP/DSDP. The initial Danian subzone, CP la, spans nearly 5 m and the underlying uppermost Maestrichtian Nephrolithus frequens Zone extends 50 m below the boundary. The paleolatitude of Broken Ridge at Cretaceous/Tertiary time is estimated at 50°-55°S which includes this site among the latest in a series of complete or near complete high southern latitude Cretaceous/Tertiary boundary sections recovered by ODP (Leg 113 Site 690 and Leg 119 Site 738). The boundary at Site 752 lies at the base of a thick (6-6.5 m) volcanic ash unit composed of multiple ash layers which overlies indurated Maestrichtian chalks. Magnetostratigraphy indicates that the boundary lies within Subchron 29R, which is the case for all other known complete sections for which the polarity has been determined. Anomalous abundances of the trace element iridium are present at the boundary. A second iridium peak, 80 cm above the boundary, corresponds to an increase in redeposited Cretaceous nannofossils. The nannofossil succession is similar to that found at previously studied austral high-latitude ODP drill sites with few differences due to the more northerly location of this site. Individual nannofossil species were counted and placed into three categories. A plot of the percent abundance of Cretaceous, Tertiary, and 'survivor' groups illustrates the rapid replacement of the Cretaceous nannoflora by 'survivor' forms beginning at the boundary and the dominance of this latter group through the initial Danian biozone. This 'survivor' or opportunistic assemblage is then rapidly replaced by newly evolved Tertiary taxa. The assemblage of the uppermost Maestrichtian is biased toward dissolution-resistant forms such as Micula decussata. In those few intervals where preservation is good, the dissolution susceptible species, Prediscosphaera stoveri, is more prevalent and overall diversity of the assemblage is higher. The 'survivor' assemblage is dominated by Zygodiscus sigmoides and Thoracosphaera. The Tertiary assemblage consists of rare Biantholithus sparsus, the first of this group to appear. It is followed several meters upsection by Cruciplacolithus primus. Cruciplacolithus tenuis and small Prinsius spp. dominate the assemblage beginning at about 5 m above the boundary.

The Prognosis of the Traumatic Subarachnoid Hemorrhage: A Prospective Report of 121 Patients

Recent investigations have shown the significance of subarachnoid bleeding on computed tomography scans first taken after admission for head injuries. In our study, we describe a prospective follow-up of 121 patients with traumatic subarachnoid hemorrhage (tSAH). From January 2004 to January 2007 we collected data prospectively from 121 patients admitted with diagnosis of tSAH to our trauma intensive care unit, on the basis of admission with a computed tomography scan. The classification of tSAH was performed using the Fisher scale with modification, and the follow-up was performed using the Glasgow Outcome Scale (GOS). The minimum period for a follow-up was established 6 months after the injury. Traffic accident was the main cause of head injuries (72% in total; 48% involving cars and 24% involving motorcycles), followed by falls (23%) and aggression (5%). Twenty-eight percent of patients sustained major multiple injuries, with spinal injury as the main associated trauma. The outcome was favorable (GOS score 4 or 5) in 54 patients (45%) and unfavorable (GOS score 1, 2, or 3) in 67 patients (55%). The mortality rate was proportionally greater in patients who had cisternal clots >1 mm (P < 0.001), assessed by the Fisher scale with modification. When functional recovery was evaluated using the GOS, the recovery rate and the daily life activities were lower in patients with intraventricular bleeding (P = 0.001). Our results showed that patients with severe tSAH had the worst prognosis.

Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry

OBJECTIVES. The purpose of this study was to obtain data on the association of antiphospholipid antibodies with clinical manifestations in childhood and to enable future studies to determine the impact of treatment and long-term outcome of pediatric antiphospholipid syndrome. PATIENTS AND METHODS. A European registry extended internationally of pediatric patients with antiphospholipid syndrome was established as a collaborative project of the European Antiphospholipid Antibodies Forum and Lupus Working Group of the Pediatric Rheumatology European Society. To be eligible for enrollment the patient must meet the preliminary criteria for the classification of pediatric antiphospholipid syndrome and the onset of antiphospholipid syndrome must have occurred before the patient`s 18th birthday. RESULTS. As of December 1, 2007, there were 121 confirmed antiphospholipid syndrome cases registered from 14 countries. Fifty-six patients were male, and 65 were female, with a mean age at the onset of antiphospholipid syndrome of 10.7 years. Sixty (49.5%) patients had underlying autoimmune disease. Venous thrombosis occurred in 72 (60%), arterial thrombosis in 39 (32%), small-vessel thrombosis in 7 (6%), and mixed arterial and venous thrombosis in 3 (2%). Associated nonthrombotic clinical manifestations included hematologic manifestations (38%), skin disorders (18%), and nonthrombotic neurologic manifestations (16%). Laboratory investigations revealed positive anticardiolipin antibodies in 81% of the patients, anti-beta(2)-glycoprotein I antibodies in 67%, and lupus anticoagulant in 72%. Comparisons between different subgroups revealed that patients with primary antiphospholipid syndrome were younger and had a higher frequency of arterial thrombotic events, whereas patients with antiphospholipid syndrome associated with underlying autoimmune disease were older and had a higher frequency of venous thrombotic events associated with hematologic and skin manifestations. CONCLUSIONS. Clinical and laboratory characterization of patients with pediatric antiphospholipid syndrome implies some important differences between antiphospholipid syndrome in pediatric and adult populations. Comparisons between children with primary antiphospholipid syndrome and antiphospholipid syndrome associated with autoimmune disease have revealed certain differences that suggest 2 distinct subgroups. Pediatrics 2008; 122: e1100-e1107

Health and Social Care: Comparative Data for Northern Ireland and other Countries - May 2004 (PDF 121 KB)

Health and Social Care: Comparative Data for Northern Ireland and other Countries - May 2004

Oral Health Strategy - General Dental Services (PDF 121 KB)

Equality Impact Assessments

Pièces diverses, manuscrites et imprimées, concernant les affaires ecclésiastiques en Lorraine (VIIIe-XVIIIe siècle). XVI — 752-1729. — Abbayes et prieurés (IV).

Contient : Épinal (1303-1661) ; Etival (1554-1719) ; Flabémont, mss. et impr., in-4° (1526-1675) ; Flavigny : comptes des revenus du prieuré (1657) ; Freistroff (1644-1712) ; Gorze : copies et factums, impr., in-4° (752-XVIIe siècle) ; Grafenthal (1554-1556) ; Grimaucourt-près-Sampigny (1639-1720) ; Hauteseille (1585) ; Herbitzheim ; originaux et copies (1284-XVIe siècle) ; Hornbach (1513)

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.

PURPOSE: In contrast to other human tumors, a repression of the cell-surface glycoprotein CD44 on neuroblastoma is a marker of aggressiveness that usually correlates to N-myc amplification. We thus compared the prognostic value of both markers in the initial staging of 121 children treated for neuroblastoma in collaborative institutions. METHODS: Frozen samples were analyzed by a rapid and well-standardized technique of immunostaining with monoclonal antibodies (MoAbs) against epitopes in the CD44 constant region. RESULTS: In this retrospective series, CD44 was expressed on 102 specimens and strongly correlated with favorable tumor stages and histology, younger age, and normal N-myc copy numbers. In univariate analysis, CD44 expression and normal N-myc were the most powerful markers of favorable clinical outcome (P < 10(-6) and chi 2 = 65.40 and P < 10(-6) and chi 2 = 42.56, respectively), but analysis of CD44 affords significant prognostic discrimination in subgroups of patients with or without N-myc-amplified tumors. In the subgroup of stage IV neuroblastomas, CD44 was the only significant prognostic marker (P < .02, chi 2 = 5.76), whereas N-myc status was not discriminant. In multivariate analysis of five factors, ie, N-myc amplification, CD44 expression, age, tumor stage, and histology, the only independent prognostic factors of event-free survival were CD44 expression and tumor stage. CONCLUSION: The analysis of CD44 cell-surface expression must be recommended as an additional biologic marker in the initial staging of the disease.

Friday Facts, November 4, 2011, Vol. 121

Bureau of Nutrition and Health Promotion part of the Iowa Department of Public Health produces of weekly newsletter about the Iowa WIC Program for the State of Iowa citizen.

Varaosaluettelo N:o 121 Chevrolet 6-syl. mallit 1929-1938

kuv., 20 x 27 cm